iTeos Therapeutics (NASDAQ:ITOS) Price Target Lowered to $19.00 at Wells Fargo & Company
iTeos Therapeutics (NASDAQ:ITOS – Get Free Report) had its target price decreased by analysts at Wells Fargo & Company from $31.00 to $19.00 in a report issued on Thursday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Wells Fargo & Company‘s target price indicates a potential upside of 161.71% from the stock’s […]
More Stories
AnaptysBio (NASDAQ:ANAB) Given New $36.00 Price Target at JPMorgan Chase & Co.
AnaptysBio (NASDAQ:ANAB – Get Free Report) had its target price decreased by equities research analysts at JPMorgan Chase & Co....
Stock Traders Purchase Large Volume of Put Options on iShares U.S. Real Estate ETF (NYSEARCA:IYR)
iShares U.S. Real Estate ETF (NYSEARCA:IYR – Get Free Report) was the target of unusually large options trading activity on...
Profound Medical (NASDAQ:PROF) & Assure (NASDAQ:IONM) Head-To-Head Analysis
Profound Medical (NASDAQ:PROF – Get Free Report) and Assure (NASDAQ:IONM – Get Free Report) are both small-cap medical companies, but...
COVID-19 Vaccine Makers and Providers Granted Immunity Through 2029
By Sherami Tsai The Biden administration has extended liability protections for COVID-19 vaccine makers, health care providers, and others through...
Georgia Appeals Court Disqualifies Fani Willis From Trump Election Case
By Jack Phillips A Georgia appeals court has disqualified Fulton County District Attorney Fani Willis from her election-related criminal case...
Toll Brothers (NYSE:TOL) Shares Gap Down – What’s Next?
Toll Brothers, Inc. (NYSE:TOL – Get Free Report)’s stock price gapped down before the market opened on Thursday . The...